Topical Data | Health & Pharmaceutical Marketing Research | MD Analytics Inc.
Menu

Topical Data

Our topical polls and independent studies provide free pharmaceutical and health industry insights from healthcare professionals and patient perspectives. The infographic accompanying each article can be downloaded and shared with attribution.

The Performance Of Patient Support Providers During The Pandemic

The Performance Of Patient Support Providers During The Pandemic

We surveyed 152 physicians in the U.S. to gauge their opinions on Patient Support Program (PSPs) providers during the pandemic. Physicians surveyed include GPs, Hematologists, Medical Oncologists, Rheumatologists, Pulmonologists, Endocrinologists and Infectious Disease Specialists. Overall perceptions of PSPs compared to before the pandemic have generally improved – especially in terms of responsiveness and the expertise of individuals working on PSPs.

read more
Pandemic Impact On Patient Support Programs

Pandemic Impact On Patient Support Programs

PSPs play a significant role in ensuring that patients have the best possible experience during their journey – especially in specialty therapeutic areas where treatments tend to be more expensive. The pandemic has made it more challenging for patients to access support and services for their medical conditions. This has put additional pressure on company-sponsored PSPs to further enhance their offerings to help patients in the best way possible.

PSPs have become increasingly important for patients since the onset of the COVID-19 pandemic and as a result now have an even more significant influence on physicians’ treatment selection process. For the most part, physicians acknowledge that PSP providers have adjusted well to the new reality brought forth by COVID-19. About a third even think that PSP providers have improved their performance since the onset of the pandemic.

read more
How Patient Support Program Providers Adjusted To The Pandemic

How Patient Support Program Providers Adjusted To The Pandemic

Physicians feel positive about how Patient Support Programs (PSPs) have evolved in the past two years – especially in terms of responsiveness and the expertise of individuals working on PSPs. The main unmet needs at this time remain the range of service hours and the availabilityof nurses remotely (either by phone or virtually). Many specialists believe that biosimilar PSP providers have struggled more than originator drug PSPs since the onset of the pandemic – mainly because of they do not have as many employees and offer a smaller range of services.

read more
COVID-19 Impact on Patient Support Programs

COVID-19 Impact on Patient Support Programs

Patient Support Programs (PSPs) play a significant role in ensuring that patients have the best possible experience during their journey – especially in specialty therapeutic areas where treatments tend to be more expensive. The COVID-19 pandemic has made it more challenging for patients to access support and services for their medical conditions. This has put additional pressure on company-sponsored PSPs to further enhance their offerings to help patients in the best way possible. PSPs have become increasingly important for patients since the onset of the COVID-19 pandemic and as a result now have an even more significant influence on physicians’ treatment selection process.

read more
In-person Interactions With Pharma Will Return

In-person Interactions With Pharma Will Return

While the vaccination campaign in the U.S. is progressing, COVID-19 continues to significantly impact healthcare practices. As knowledge about the virus evolved during the pandemic, physicians and other HCPs have continuously adapted how they manage their patients and how they interact with key stakeholders. Half of the physicians surveyed expect to see increased workloads as 2021 draws to a close. Patient volumes continue to inch closer to pre-pandemic levels and requests for diagnostic testing along with treatment switches have now exceeded pre-pandemic levels.

MD Analytics has been monitoring these trends and we are excited to share with you our new downloadable infographic on this topic.

read more
Virtual Interactions With Pharma Are Here To Stay

Virtual Interactions With Pharma Are Here To Stay

While the vaccination campaign in Canada has shown positive progress, the COVID-19 pandemic continues to significantly impact the way in which HCPs interact with both patients and pharma.  MD Analytics has been monitoring these trends over the past year and we are excited to share with you our 4th wave infographic on this topic.

For the first time since initiating this tracking study, patient volumes have returned back to pre-pandemic conditions, as have key measures such are diagnostic tests performed and treatment switches. It is important to note that while most physicians feel that their workloads are now similar to pre-COVID conditions, many expect to exceed their current levels in the coming months.

read more
COVID-19 Impact on Women in Pharma

COVID-19 Impact on Women in Pharma

The COVID-19 crisis changed the way people work across industries including the pharma industry. MD Analytics teamed up with the professional association for women in the pharma industry Women Leaders in Pharma to conduct a study on the impact on of COVID-19 on women who work in the pharma industry.

read more
How COVID-19 is affecting HCPs as vaccinations take hold

How COVID-19 is affecting HCPs as vaccinations take hold

As the COVID-19 vaccination campaign ramped up in the Spring, and rates of infection dropped, a return to normality appeared to be on the horizon. However, with widespread vaccine hesitancy paired with the virulent spread of the delta variant, we are once again left with an uncertain view of the future.

Throughout the past year, MD Analytics has been monitoring the effects of this uncertainty, and the pandemic in general, on the practices and perceptions of HCPs. Ongoing changes in workloads, patient assessments, and interactions with pharma have had direct and meaningful impact on the healthcare industry.

read more
Pandemic’s Impact on HCPs Practices and Vaccination Campaign Perceptions

Pandemic’s Impact on HCPs Practices and Vaccination Campaign Perceptions

The COVID-19 vaccination campaign is underway in Canada. However, the pandemic has significantly altered HCPs’ practices to date. These changes have impacted workloads, patient assessments, and interactions with pharma. A year into the pandemic, a national COVID-19 vaccination campaign is underway. This begs the question, how are Canadian HCPs doing today? What do they foresee moving forward? Our latest short survey presents the current state of HCPs’ practices in Canada and their assessment of the government’s management of COVID-19.

read more
Remote detailing for pharma – Physicians’ perspectives

Remote detailing for pharma – Physicians’ perspectives

The detailing of healthcare providers through virtual means has become a staple for pharmaceutical brands and is essential for any go-to-market strategy. When face-to-face detailing was put on hold this past year, healthcare providers began experiencing an even greater volume of requests for virtual interactions. For pharma brand teams, ensuring your approach to digital communications matches with the preferences of providers is important in helping your messages get through to your target prescribers.

In our latest quick poll, conducted in March 2021, MD Analytics sought to gain clarity around current remote detailing preferences and identify the components of an “ideal” remote interaction.

read more
The Future of Medical Conferences is Virtual

The Future of Medical Conferences is Virtual

Each year, providers and health industry professionals travel from locations around the world to share and discuss the latest developments in medical care. For several years now, conferences have been experimenting with digital features that allow participants to engage remotely, avoiding the burdens of travel. However, the scope of content available to digital participants had often been limited and physician adoption was low.

read more
Physician Use of Social Media

Physician Use of Social Media

Physicians are using social media in their personal and professional lives, especially younger physicians. However, the pharma industry should be aware of barriers to using social media as a means of interacting professionally with physicians, such as the perceived reliability of online information.

read more
Customer Engagement in the Pharmaceutical Industry – Why channels of communication matter

Customer Engagement in the Pharmaceutical Industry – Why channels of communication matter

Measuring customer engagement in pharmaceutical market research can be challenging as physicians usually prefer to not be seen as “associated” with any given pharmaceutical company. However, as demonstrated by our customer engagement syndicated study, it is undeniable that stronger levels of physician engagement exist among pharmaceutical companies which can lead to more positive outcomes for their associated brands.

read more
A Guide to Successful Qualitative Research

A Guide to Successful Qualitative Research

Qualitative research can provide a greater understanding of physicians’ attitudes and behaviours than quantitative methodologies, however increased demands on physician time may cause some to refuse participating. Determining the optimal study design and appropriate recruitment techniques can help make physicians more willing to participate.

read more
Best Channels to Educate Dental Professionals

Best Channels to Educate Dental Professionals

Dental professionals turn to traditional information channels most often when sourcing information on manufacturer products and continuing education. However, more innovative tools such as online and digital offerings continue to grow in importance, especially among newer dental professionals. Find out how to make sure your future outreach efforts are ready for the next generation of dental professionals.

read more

We are here to answer your questions.